# Extension to a Pivotal Study of Sensory Stimulation in Alzheimer's Disease (OLE Hope Study, CA-0015)

> **NCT06245031** · NA · ENROLLING_BY_INVITATION · sponsor: **Cognito Therapeutics, Inc.** · enrollment: 402 (estimated)

## Conditions studied

- Alzheimer Disease
- Cognitive Impairment
- Mild Cognitive Impairment
- Dementia, Mild
- Dementia Moderate
- Dementia Alzheimers
- Dementia of Alzheimer Type
- AD

## Interventions

- **DEVICE:** Sensory Stimulation System (GS120) - Active

## Key facts

- **NCT ID:** NCT06245031
- **Lead sponsor:** Cognito Therapeutics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2024-02-29
- **Primary completion:** 2026-12
- **Final completion:** 2027-03
- **Target enrollment:** 402 (ESTIMATED)
- **Last updated:** 2024-05-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06245031

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06245031, "Extension to a Pivotal Study of Sensory Stimulation in Alzheimer's Disease (OLE Hope Study, CA-0015)". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06245031. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*